3D Bioprinting Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural, Synthetic, Hybrid)), Material (Hydrogel, Living Cells), Application (Research, Clinical), End User (Biopharma, Academia) & Region - Global Forecasts to 2027

FREE BROCHURE FREE SAMPLE REPORT

Report Code: BT 4971 Jul, 2022, by marketsandmarkets.com

Updated on : March 21, 2023

The global 3D bioprinting market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $3.3 billion by 2027, growing at a CAGR of 20.8% from 2022 to 2027.

The new version of the report includes the startup/SME company evaluation quadrant for 15 companies operating in the market. This updated section is the output of a comprehensive study of the key startup vendors offering 3D bioprinting products. From a list of more than 50 vendors, the top 15 were chosen. These vendors were evaluated based on market share, ranking, and product footprint, rated, and positioned on a 2x2 quadrant. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities are driving market growth. However, a dearth of skilled professionals and high development and production costs are restraining the growth of this market.

3D Bioprinting Market

To know about the assumptions considered for the study, Request for Free Sample Report

3D Bioprinting Market Dynamics

Drivers: Increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries

The increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries has been a major driver of the market. 3D bioprinting enables the production of complex 3D structures, which are difficult to produce using traditional methods. This has enabled the production of complex drug molecules and formulations, as well as cosmetic products such as artificial skin, hair follicles, and other tissues. The increasing demand for 3D bioprinted products in the pharmaceutical and cosmetic industries has been a major driver of the market.

Opportunities: Rising demand for organ transplants

3D bioprinting is a rapidly growing field in the medical industry. It is a process of creating living tissues and organs from a computer aided design model. This technology has the potential to revolutionize the way medical treatments are done. 3D bioprinting has the potential to address the ever increasing demand for organ transplants, which is currently outstripping the available donor organs. This technology can provide an ethical and efficient approach to creating organs for transplant. Additionally, 3D bioprinting has the potential to reduce costs associated with organ transplants. As the technology continues to improve, the market for 3D bioprinting is expected to grow significantly in the coming years.

Restraints: Dearth of skilled professionals

The dearth of skilled professionals in the market is one of the major restraints of the market. The lack of skilled professionals has hindered the growth of the market as the demand for advanced 3D bioprinting technology is increasing. The requirement of skilled professionals to operate and maintain 3D bioprinting equipment is needed. The lack of skilled professionals has decreased the chances of 3D bioprinting technology to reach its full potential. Additionally, the high cost associated with training and hiring skilled professionals is further hampering the market growth.

Challenges: Process control and understanding of 3D bioprinters

One of the major challenges in the market is the process control and understanding of 3D bioprinters. The 3D bioprinters require precise control over the material and process parameters, such as temperature, pressure, and composition of the material being printed. Due to the complexity of the process, it can be difficult to understand and control the bioprinting process. This can lead to inaccurate results and potential damage to the printed material. To address this challenge, 3D bioprinting companies have developed dedicated software that can help manage the printing process and optimize its settings. Additionally, the use of automated process control systems can help ensure more consistent results. Additionally, research is being conducted to improve the understanding of the 3D bioprinting process and develop improved bioprinting materials.

The component segment and 3D bioprinters subsegment dominated the 3D bioprinting market.

On the basis of component, the market is segmented into 3D bioprinters and bioinks. 3D bioprinters accounted for the largest market share in 2021. Factors such as technological advancements and the growing demand for organ transplants are driving the growth of this segment.

3D Bioprinting Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for the 3D bioprinting market.

North America accounted for the largest share of the market in 2021. The significant government and private investments to develop advanced 3D bioprinting technologies, the high adoption rate of these technologies, and the presence of key market players in the region all contribute to a large share of North America in the market.

Key players in the global 3D bioprinting market include BICO Group AB (US), Organovo Holdings Inc. (US), Allevi, Inc. (part of 3D Systems, Inc.) (US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), EnvisionTEC GmbH (part of Desktop Metal, Inc.) (Germany), Aspect Biosystems Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), and Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China).

3D Bioprinting Market Report Scope:

Report Metric	Details
Market Revenue in 2022	$1.3 billion
Estimated Value by 2027	$3.3 billion
Growth Rate	Poised to grow at a CAGR of 20.8%
Market Segmentation	By Product and Region
Market Driver	Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries
Market Opportunity	Rising demand for organ transplants
Geographies covered	North America, Europe, APAC, MEA, and Latin America

This research report categorizes the 3D bioprinting market into following segments & sub-segments:

By Component

3D Bioprinters
Bioinks

By Application

Research applications
Clinical applications

By End user

Research Organizations and Academic Institutes,
Biopharmaceutical companies
Hospitals

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
Asia Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific (RoAPAC)
Latin America (LATAM)
Middle East and Africa (MEA)

Recent Developments

In March 2022, BICO Group AB (US) launched the BIO CELLX, which is a novel system that automates 3D cell culture workflows by leveraging prevalidated protocols.
In June 2021, 3D Systems, Inc. (US) and CollPlant Biotechnologies Ltd. (Israel) signed a co-development agreement for a 3D-bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant.

Frequently Asked Questions (FAQs):

What is the projected market value of the global 3D bioprinting market?

The global market of 3D bioprinting is projected to reach USD 3.3 billion.

What is the estimated growth rate (CAGR) of the global 3D bioprinting market for the next five years?

The global 3D bioprinting market is projected to grow at a Compound Annual Growth Rate (CAGR) of 20.8% from 2022 to 2027.

What are the major revenue pockets in the 3D bioprinting market currently?

The global is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America dominated the market, followed by Europe. The significant government and private investments to develop advanced 3D bioprinting technologies, the high adoption rate of these technologies, and the presence of key market players in the region are responsible for the large share of North America in the 3D bioprinting market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 37)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 42)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
           FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
           FIGURE 6 GLOBAL MARKET (SUPPLY SIDE): CAGR PROJECTIONS
           FIGURE 7 MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
           2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 52)
    FIGURE 9 3D BIOPRINTING MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 MARKET, BY MATERIAL, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 56)
    4.1 3D BIOPRINTING MARKET OVERVIEW
           FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN 3D BIOPRINTING INDUSTRY TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET, BY COMPONENT AND COUNTRY (2021)
           FIGURE 15 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
    4.3 MARKET SHARE, BY MATERIAL, 2022 VS. 2027
           FIGURE 16 LIVING CELLS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
    4.4 MARKET SHARE, BY END USER, 2022
           FIGURE 17 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE LARGEST END USERS OF MARKET
    4.5 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. - 59)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing use of 3D bioprinting in pharmaceutical and cosmetology industries
                    5.2.1.2 Developments in 3D bioprinting for tissue and organ regeneration applications
                    5.2.1.3 Rising public and private funding to support bioprinting research activities
                    5.2.1.4 Technological advancements in 3D bioprinting industry
           5.2.2 RESTRAINTS
                    5.2.2.1 Dearth of skilled professionals
                    5.2.2.2 High development and production costs
                    5.2.2.3 Lack of regulatory guidelines governing 3D bioprinting
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising demand for organ transplant
                    5.2.3.2 Growing awareness of 3D bioprinting
                    5.2.3.3 Growing demand for regenerative medicine and stem cell research
           5.2.4 CHALLENGES
                    5.2.4.1 Socioethical concerns related to use of 3D-bioprinted products
                    5.2.4.2 High cost of 3D bioprinting
                    5.2.4.3 Process control and understanding of 3D bioprinters
    5.3 RANGES/SCENARIOS
           FIGURE 20 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF GLOBAL MARKET
    5.4 IMPACT OF COVID-19 ON MARKET
           FIGURE 21 MARKET SCENARIO PRE- AND POST-COVID-19, 2020–2022
           FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    5.5 PRICING ANALYSIS
    5.6 TECHNOLOGY ANALYSIS
           TABLE 1 COMPARISON OF BIOPRINTING TECHNIQUES
           TABLE 2 ADVANTAGES AND DISADVANTAGES OF 3D BIOPRINTING TECHNIQUES
    5.7 PATENT ANALYSIS
           FIGURE 23 PATENT APPLICATIONS FOR MARKET, JANUARY 2011–MAY 2022
           TABLE 3 INDICATIVE LIST OF PATENTS IN MARKET
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 24 VALUE CHAIN ANALYSIS OF MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
           5.8.1 RESEARCH & DEVELOPMENT (R&D)
           5.8.2 MANUFACTURING & ASSEMBLY
           5.8.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    5.9 SUPPLY CHAIN ANALYSIS
           5.9.1 PROMINENT COMPANIES
           5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES (SMES)
           5.9.3 END USERS
                    FIGURE 25 MARKET: SUPPLY CHAIN ANALYSIS
    5.10 ECOSYSTEM ANALYSIS OF GLOBAL MARKET
           TABLE 4 SUPPLY CHAIN ECOSYSTEM
    5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
           TABLE 5 GLOBAL MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 REGULATORY ANALYSIS
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 PORTER’S FIVE FORCES ANALYSIS
           TABLE 10 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF SUPPLIERS
           5.13.4 BARGAINING POWER OF BUYERS
           5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF 3D BIOPRINTING PRODUCTS
           5.14.2 BUYING CRITERIA FOR 3D BIOPRINTING PRODUCTS
                     FIGURE 27 KEY BUYING CRITERIA FOR END USERS

6 3D BIOPRINTING MARKET, BY COMPONENT (Page No. - 81)
    6.1 INTRODUCTION
           TABLE 11 MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
    6.2 3D BIOPRINTERS
           6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY
           TABLE 12 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
           TABLE 13 3D BIOPRINTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 14 NORTH AMERICA: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 15 EUROPE: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 16 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.1 Microextrusion bioprinting
                               6.2.1.1.1 Increasing research in microextrusion fueling adoption of this technology
                                            TABLE 17 MICROEXTRUSION MARKET, BY REGION, 2020–2027 (USD MILLION)
                                            TABLE 18 NORTH AMERICA: MICROEXTRUSION 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 19 EUROPE: MICROEXTRUSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 20 ASIA PACIFIC: MICROEXTRUSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.2 Inkjet 3D bioprinting
                               6.2.1.2.1 High cell viability and low cost resulted in increased demand for inkjet 3D bioprinting
                                            TABLE 21 INKJET MARKET, BY REGION, 2020–2027 (USD MILLION)
                                            TABLE 22 NORTH AMERICA: INKJET MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 23 EUROPE: INKJET MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 24 ASIA PACIFIC: INKJET MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.3 Laser-assisted bioprinting
                               6.2.1.3.1 Laser-assisted bioprinting among highest-resolution bioprinting technologies available in 3D bioprinting industry
                                            TABLE 25 LASER-ASSISTED MARKET, BY REGION, 2020–2027 (USD MILLION)
                                            TABLE 26 NORTH AMERICA: LASER-ASSISTED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 27 EUROPE: LASER-ASSISTED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 28 ASIA PACIFIC: LASER-ASSISTED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.4 Stereolithography-based bioprinting
                               6.2.1.4.1 Stereolithography offers high printing quality, speed, and cell viability
                                            TABLE 29 STEREOLITHOGRAPHY-BASED MARKET, BY REGION, 2020–2027 (USD MILLION)
                                            TABLE 30 NORTH AMERICA: STEREOLITHOGRAPHY-BASED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 31 EUROPE: STEREOLITHOGRAPHY-BASED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 32 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.5 Magnetic 3D bioprinting
                               6.2.1.5.1 Accuracy and speed are major advantages of magnetic 3D bioprinting
                                            TABLE 33 MAGNETIC 3D BIOPRINTING MARKET, BY REGION, 2020–2027 (USD MILLION)
                                            TABLE 34 NORTH AMERICA: MAGNETIC MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 35 EUROPE: MAGNETIC MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                            TABLE 36 ASIA PACIFIC: MAGNETIC MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.6 Other technologies
                               TABLE 37 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 38 NORTH AMERICA: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 39 EUROPE: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 40 ASIA PACIFIC: 3D BIOPRINTERS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 BIOINKS
           TABLE 41 BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 42 BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 43 NORTH AMERICA: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 44 EUROPE: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 45 ASIA PACIFIC: BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.1 NATURAL BIOINKS
                    6.3.1.1 Natural bioinks most preferred bioink in 3D bioprinting process
                               TABLE 46 NATURAL BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 47 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 48 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 49 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.2 HYBRID BIOINKS
                    6.3.2.1 Hybrid bioinks possess high mechanical strength and biocompatibility
                               TABLE 50 HYBRID BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 51 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 52 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 53 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.3 SYNTHETIC BIOINKS
                    6.3.3.1 Improved mechanical strength and consistency offered by synthetic bioinks to drive market
                               TABLE 54 SYNTHETIC BIOINKS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 55 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 56 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 57 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 3D BIOPRINTING MARKET, BY MATERIAL (Page No. - 106)
    7.1 INTRODUCTION
           TABLE 58 MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
    7.2 LIVING CELLS
           7.2.1 ETHICAL ISSUES ASSOCIATED WITH USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH
                    TABLE 59 MARKET FOR LIVING CELLS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 60 NORTH AMERICA: MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 61 EUROPE: MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 62 ASIA PACIFIC: MARKET FOR LIVING CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 HYDROGELS
           7.3.1 DYNAMIC PROPERTIES OF HYDROGELS SUPPORT THEIR ADOPTION IN 3D TISSUE ENGINEERING
                    TABLE 63 MARKET FOR HYDROGELS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 64 NORTH AMERICA: MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 65 EUROPE: MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 66 ASIA PACIFIC: MARKET FOR HYDROGELS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 EXTRACELLULAR MATRICES
           7.4.1 ECM HAS EMERGED AS PROMISING TOOL IN TISSUE ENGINEERING
                    TABLE 67 MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 68 NORTH AMERICA: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 69 EUROPE: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 OTHER BIOMATERIALS
           TABLE 71 MARKET FOR OTHER BIOMATERIALS, BY REGION, 2020–2027 (USD MILLION)
           TABLE 72 NORTH AMERICA: MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 73 EUROPE: MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 74 ASIA PACIFIC: MARKET FOR OTHER BIOMATERIALS, BY COUNTRY, 2020–2027 (USD MILLION)

8 3D BIOPRINTING MARKET, BY APPLICATION (Page No. - 118)
    8.1 INTRODUCTION
           TABLE 75 MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 RESEARCH APPLICATIONS
           TABLE 76 MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 77 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
           TABLE 78 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 79 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 80 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.1 DRUG RESEARCH
                    8.2.1.1 Drug research is largest and fastest-growing segment of market
                               TABLE 81 MARKET FOR DRUG RESEARCH, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 82 NORTH AMERICA: MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 83 EUROPE: MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 84 ASIA PACIFIC: MARKET FOR DRUG RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.2 REGENERATIVE MEDICINE
                    8.2.2.1 Growing demand for organ transplant to support market growth
                               TABLE 85 MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 86 NORTH AMERICA: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 87 EUROPE: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 88 ASIA PACIFIC: MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.3 3D CELL CULTURE
                    8.2.3.1 Rising focus on developing alternatives to animal testing to drive market for 3D cell culture
                               TABLE 89 MARKET FOR 3D CELL CULTURE, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 90 NORTH AMERICA: MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 91 EUROPE: MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 92 ASIA PACIFIC: MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 CLINICAL APPLICATIONS
           TABLE 93 MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           TABLE 94 MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
           TABLE 95 NORTH AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 96 EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 97 ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.1 SKIN
                    8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth
                               TABLE 98 MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 99 NORTH AMERICA: MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 100 EUROPE: MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 101 ASIA PACIFIC: MARKET FOR SKIN BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.2 BONE AND CARTILAGE
                    8.3.2.1 Increasing incidence of musculoskeletal conditions to drive demand for bone grafts
                               TABLE 102 MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 103 NORTH AMERICA: MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 104 EUROPE: MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 105 ASIA PACIFIC: MARKET FOR BONE AND CARTILAGE BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.3 BLOOD VESSELS
                    8.3.3.1 Increasing research activities focused on 3D bioprinting of blood vessels major factor driving market
                               TABLE 106 MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 107 NORTH AMERICA: MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 108 EUROPE: MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 109 ASIA PACIFIC: MARKET FOR BLOOD VESSEL BIOPRINTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.4 OTHER CLINICAL APPLICATIONS
                    TABLE 110 LIST OF ONGOING CLINICAL TRIALS
                    TABLE 111 MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 112 NORTH AMERICA: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 113 EUROPE: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 114 ASIA PACIFIC: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

9 3D BIOPRINTING MARKET, BY END USER (Page No. - 142)
    9.1 INTRODUCTION
           TABLE 115 MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
           9.2.1 RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES ARE FASTEST-GROWING END USERS OF MARKET
                    TABLE 116 MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 117 NORTH AMERICA: MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 118 EUROPE: MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 119 ASIA PACIFIC: MARKET FOR RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 BIOPHARMACEUTICAL COMPANIES
           9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF 3D BIOPRINTING
                    TABLE 120 MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 121 NORTH AMERICA: MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 122 EUROPE: MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 123 ASIA PACIFIC: MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 HOSPITALS
           9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS
                    TABLE 124 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 125 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 126 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 127 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)

10 3D BIOPRINTING MARKET, BY REGION (Page No. - 151)
     10.1 INTRODUCTION
             TABLE 128 MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 28 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
             TABLE 129 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 130 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 131 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 132 NORTH AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 133 NORTH AMERICA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
             TABLE 134 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 135 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 136 NORTH AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 137 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US dominates global 3D bioprinting market
                                     TABLE 138 US: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 139 US: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 140 US: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 141 US: 3D BIOINKS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 142 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 143 US: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 144 US: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 145 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government initiatives to support growth of 3D bioprinting market in Canada
                                     TABLE 146 CANADA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 147 CANADA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 148 CANADA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 149 CANADA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 150 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 151 CANADA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 152 CANADA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 153 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 154 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 155 EUROPE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 156 EUROPE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 157 EUROPE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 158 EUROPE: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
             TABLE 159 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 160 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 161 EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 162 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing demand for organ transplant to drive market
                                     TABLE 163 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 164 GERMANY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 165 GERMANY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 166 GERMANY: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 167 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 168 GERMANY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 169 GERMANY: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 170 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Increased funding and grants to support research activities related to 3D bioprinting in UK
                                     TABLE 171 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 172 UK: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 173 UK: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 174 UK: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 175 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 176 UK: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 177 UK: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 178 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Rising adoption of 3D bioprinting technology to propel market growth
                                     TABLE 179 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 180 FRANCE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 181 FRANCE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 182 FRANCE: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 183 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 184 FRANCE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 185 FRANCE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 186 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Italy is leading life science research hub in Europe
                                     TABLE 187 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 188 ITALY: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 189 ITALY: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 190 ITALY: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 191 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 192 ITALY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 193 ITALY: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 194 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain
                                     TABLE 195 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 196 SPAIN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 197 SPAIN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 198 SPAIN: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 199 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 200 SPAIN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 201 SPAIN: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 202 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 203 ROE: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 204 ROE: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 205 ROE: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 206 ROE: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 207 ROE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 208 ROE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 209 ROE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 210 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 29 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
             TABLE 211 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 212 ASIA PACIFIC: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 213 ASIA PACIFIC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
             TABLE 214 ASIA PACIFIC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 215 ASIA PACIFIC: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
             TABLE 216 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 217 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 218 ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 219 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Market in China projected to register significant growth owing to rising regenerative medicine research
                                     TABLE 220 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 221 CHINA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 222 CHINA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 223 CHINA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 224 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 225 CHINA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 226 CHINA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 227 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Strong research base and government support to drive market for 3D bioprinting in Japan
                                     TABLE 228 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 229 JAPAN: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 230 JAPAN: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 231 JAPAN: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 232 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 233 JAPAN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 234 JAPAN: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 235 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Initiatives to raise awareness and develop novel products to support market growth
                                     TABLE 236 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 237 INDIA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 238 INDIA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 239 INDIA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 240 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 241 INDIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 242 INDIA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 243 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 SOUTH KOREA
                        10.4.4.1 Increased awareness about 3D bioprinting to drive market in South Korea
                                     TABLE 244 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 245 SOUTH KOREA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                     TABLE 246 SOUTH KOREA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 247 SOUTH KOREA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                     TABLE 248 SOUTH KOREA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 249 SOUTH KOREA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 250 SOUTH KOREA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 251 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 252 ROAPAC: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 253 ROAPAC: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 254 ROAPAC: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 255 ROAPAC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 256 ROAPAC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 257 ROAPAC: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 258 ROAPAC: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 259 ROAPAC: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 GROWING MEDICAL TOURISM TO DRIVE MARKET FOR 3D BIOPRINTING IN LATIN AMERICA
                        TABLE 260 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 261 LATIN AMERICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 262 LATIN AMERICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 263 LATIN AMERICA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 264 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 265 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 266 LATIN AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 267 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST AND AFRICA
             10.6.1 GROWING RESEARCH EFFORTS TO BOOST MARKET GROWTH
                        TABLE 268 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 269 MIDDLE EAST AND AFRICA: 3D BIOPRINTERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                        TABLE 270 MIDDLE EAST AND AFRICA: BIOINKS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 271 MIDDLE EAST AND AFRICA: MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 272 MIDDLE EAST AND AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 273 MIDDLE EAST AND AFRICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 274 MIDDLE EAST AND AFRICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 275 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 215)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 30 KEY DEVELOPMENTS IN 3D BIOPRINTING MARKET, 2019–2022
     11.3 MARKET SHARE ANALYSIS
             FIGURE 31 GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
             TABLE 276 GLOBAL MARKET: DEGREE OF COMPETITION
     11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 32 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN GLOBAL MARKET, 2019–2021
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 33 GLOBAL MARKET: COMPANY EVALUATION QUADRANT, 2021
     11.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 34 3D BIOPRINTING MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
     11.7 COMPANY FOOTPRINT ANALYSIS
             11.7.1 PRODUCT FOOTPRINT OF COMPANIES
                        TABLE 277 PRODUCT FOOTPRINT OF COMPANIES IN GLOBAL MARKET (2021)
             11.7.2 REGIONAL FOOTPRINT OF COMPANIES
                        TABLE 278 REGIONAL FOOTPRINT OF COMPANIES IN GLOBAL MARKET (2021)
     11.8 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
             TABLE 279 GLOBAL MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
     11.9 COMPETITIVE SCENARIO
             TABLE 280 KEY PRODUCT LAUNCHES
             TABLE 281 KEY DEALS
             TABLE 282 OTHER KEY DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 226)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats)*
             12.1.1 BICO GROUP AB
                        TABLE 283 BICO GROUP AB: BUSINESS OVERVIEW
                        FIGURE 35 BICO GROUP AB: COMPANY SNAPSHOT (2021)
             12.1.2 ORGANOVO HOLDINGS INC.
                        TABLE 284 ORGANOVO HOLDINGS INC.: BUSINESS OVERVIEW
                        FIGURE 36 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2020)
             12.1.3 ALLEVI, INC. (PART OF 3D SYSTEMS, INC.)
                        TABLE 285 3D SYSTEMS, INC.: BUSINESS OVERVIEW
                        FIGURE 37 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2021)
             12.1.4 COLLPLANT BIOTECHNOLOGIES LTD.
                        TABLE 286 COLLPLANT BIOTECHNOLOGIES LTD.: BUSINESS OVERVIEW
                        FIGURE 38 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2021)
             12.1.5 REGENHU
                        TABLE 287 REGENHU: BUSINESS OVERVIEW
             12.1.6 ENVISIONTEC GMBH (PART OF DESKTOP METAL, INC.)
                        TABLE 288 ENVISIONTEC GMBH: BUSINESS OVERVIEW
             12.1.7 ASPECT BIOSYSTEMS LTD.
                        TABLE 289 ASPECT BIOSYSTEMS LTD.: BUSINESS OVERVIEW
             12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC
                        TABLE 290 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: BUSINESS OVERVIEW
             12.1.9 CYFUSE BIOMEDICAL K.K.
                        TABLE 291 CYFUSE BIOMEDICAL K.K.: BUSINESS OVERVIEW
             12.1.10 ROKIT HEALTHCARE, INC.
                        TABLE 292 ROKIT HEALTHCARE, INC.: BUSINESS OVERVIEW
             12.1.11 REGENOVO BIOTECHNOLOGY CO., LTD. (PART OF SHINING 3D TECH CO., LTD.)
                        TABLE 293 REGENOVO BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
             12.1.12 PANDORUM TECHNOLOGIES PVT. LTD.
                        TABLE 294 PANDORUM TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
             12.1.13 FOLDINK LIFE SCIENCE TECHNOLOGIES
                        TABLE 295 FOLDINK LIFE SCIENCE TECHNOLOGIES: BUSINESS OVERVIEW
             12.1.14 REVOTEK CO., LTD.
                        TABLE 296 REVOTEK CO., LTD.: BUSINESS OVERVIEW
             12.1.15 PRECISE BIO
                        TABLE 297 PRECISE BIO: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS
             12.2.1 BRINTER
             12.2.2 PRELLIS BIOLOGICS
             12.2.3 REGEMAT 3D
             12.2.4 3DBIO THERAPEUTICS
             12.2.5 TISSUE REGENERATION SYSTEMS INC.
             12.2.6 POIETIS
             12.2.7 SUNP BIOTECH, LLC
             12.2.8 VIVAX BIO, LLC
             12.2.9 GESIM MBH
             12.2.10 MANCHESTER BIOGEL
*Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 262)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATION
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global 3D bioprinting market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study included corporate filings (such as annual reports, SEC filings, and financial statements), research journals, press releases, and trade, business, and professional associations. These secondary sources were used to identify and collect useful information for this extensive, technical, and commercial study of the 3D bioprinting market. Secondary research was mainly used to obtain key information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, market trends, and key developments by both public and private organizations in the 3D bioprinting market.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global 3D bioprinting market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic and research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

3D Bioprinting Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the 3D bioprinting market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and market have been identified through extensive primary and secondary research.
The revenues generated from the 3D bioprinting business of leading players have been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Report Objectives

To define, describe, and forecast the 3D bioprinting market on the basis of component, application, material, end user, and region
To provide detailed information regarding the major factors influencing the market growth, such as drivers, restraints, opportunities, and challenges
To strategically analyze the micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall 3D bioprinting market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the revenue of the market segments with respect to five main regions, namely, North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, and the Rest of Asia Pacific), Latin America, and the Middle East & Africa.
To profile the key market players and comprehensively analyze their market shares and core competencies2
To track and analyze competitive developments such as product launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the 3D bioprinting market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report: